Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0002034679-25-000006

Chief Medical Officer sold 11,000 shares at an average $18.65 ($205,108)

  • Chief Medical Officer acquired 11,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Raben David Chief Medical Officer 2025-11-24 Option exercise 10b5-1 +5,500 $3.79 $20,844 40,997 D
Raben David Chief Medical Officer 2025-11-24 Sale 10b5-1 −5,500 $18.45 $101,475 35,497 D
Raben David Chief Medical Officer 2025-11-25 Option exercise 10b5-1 +4,594 $3.79 $17,410 40,091 D
Raben David Chief Medical Officer 2025-11-25 Sale 10b5-1 −4,594 $18.84 $86,562 35,497 D
Raben David Chief Medical Officer 2025-11-25 Option exercise 10b5-1 +906 $3.79 $3,434 36,403 D
Raben David Chief Medical Officer 2025-11-25 Sale 10b5-1 −906 $18.84 $17,071 35,497 D
Derivatives
Raben David Chief Medical Officer 2025-11-24 Option exercise · Stock Option (Right to Buy) 10b5-1 −5,500 123,370 D
Raben David Chief Medical Officer 2025-11-25 Option exercise · Stock Option (Right to Buy) 10b5-1 −4,594 118,776 D
Raben David Chief Medical Officer 2025-11-25 Option exercise · Stock Option (Right to Buy) 10b5-1 −906 69,413 D
Open-market sales · 11,000 sh · avg $18.65 · $205,108
Loading xslF345X05/wk-form4_1764113985.xml…